BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

485 related articles for article (PubMed ID: 27421772)

  • 1. Subcellular differential expression of Ep-ICD in oral dysplasia and cancer is associated with disease progression and prognosis.
    Somasundaram RT; Kaur J; Leong I; MacMillan C; Witterick IJ; Walfish PG; Ralhan R
    BMC Cancer; 2016 Jul; 16():486. PubMed ID: 27421772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased expression of Ep-CAM protein is significantly associated with the progression and prognosis of oral squamous cell carcinomas in Taiwan.
    Hwang EY; Yu CH; Cheng SJ; Chang JY; Chen HM; Chiang CP
    J Oral Pathol Med; 2009 Jan; 38(1):87-93. PubMed ID: 18355175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. End Binding 1 (EB1) overexpression in oral lesions and cancer: A biomarker of tumor progression and poor prognosis.
    Kumar M; Mehra S; Thakar A; Shukla NK; Roychoudhary A; Sharma MC; Ralhan R; Chauhan SS
    Clin Chim Acta; 2016 Aug; 459():45-52. PubMed ID: 27208742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of cytoplasmic S100A2 overexpression in oral cancer patients.
    Kumar M; Srivastava G; Kaur J; Assi J; Alyass A; Leong I; MacMillan C; Witterick I; Shukla NK; Thakar A; Duggal R; Roychoudhury A; Sharma MC; Walfish PG; Chauhan SS; Ralhan R
    J Transl Med; 2015 Jan; 13():8. PubMed ID: 25591983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of epithelial cell adhesion molecule (EpCAM) in oral squamous cell carcinoma.
    Sen S; Carnelio S
    Histopathology; 2016 May; 68(6):897-904. PubMed ID: 26401964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuclear Ep-ICD expression is a predictor of poor prognosis in "low risk" prostate adenocarcinomas.
    Assi J; Srivastava G; Matta A; MacMillan C; Ralhan R; Walfish PG
    PLoS One; 2015; 10(2):e0107586. PubMed ID: 25695234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nuclear Ep-ICD accumulation predicts aggressive clinical course in early stage breast cancer patients.
    Srivastava G; Assi J; Kashat L; Matta A; Chang M; Walfish PG; Ralhan R
    BMC Cancer; 2014 Sep; 14():726. PubMed ID: 25265904
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuclear heterogeneous nuclear ribonucleoprotein D is associated with poor prognosis and interactome analysis reveals its novel binding partners in oral cancer.
    Kumar M; Matta A; Masui O; Srivastava G; Kaur J; Thakar A; Shukla NK; RoyChoudhury A; Sharma M; Walfish PG; Michael Siu KW; Chauhan SS; Ralhan R
    J Transl Med; 2015 Aug; 13():285. PubMed ID: 26318153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemistry of YAP and dNp63 and survival analysis of patients bearing precancerous lesion and oral squamous cell carcinoma.
    Ono S; Nakano K; Takabatake K; Kawai H; Nagatsuka H
    Int J Med Sci; 2019; 16(5):766-773. PubMed ID: 31217745
    [No Abstract]   [Full Text] [Related]  

  • 10. An Ep-ICD based index is a marker of aggressiveness and poor prognosis in thyroid carcinoma.
    He HC; Kashat L; Kak I; Kunavisarut T; Gundelach R; Kim D; So AK; MacMillan C; Freeman JL; Ralhan R; Walfish PG
    PLoS One; 2012; 7(9):e42893. PubMed ID: 23049733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loss of DLC1 is an independent prognostic factor in patients with oral squamous cell carcinoma.
    Tripathi SC; Kaur J; Matta A; Gao X; Sun B; Chauhan SS; Thakar A; Shukla NK; Duggal R; Choudhary AR; DattaGupta S; Sharma MC; Ralhan R; Siu KW
    Mod Pathol; 2012 Jan; 25(1):14-25. PubMed ID: 22002576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical analysis based Ep-ICD subcellular localization index (ESLI) is a novel marker for metastatic papillary thyroid microcarcinoma.
    Kunavisarut T; Kak I; Macmillan C; Ralhan R; Walfish PG
    BMC Cancer; 2012 Nov; 12():523. PubMed ID: 23153310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High HMGA2 Expression Correlates with Reduced Recurrence-free Survival and Poor Overall Survival in Oral Squamous Cell Carcinoma.
    Fang CY; Liew PL; Chen CL; Lin YH; Fang CL; Chen WY
    Anticancer Res; 2017 Apr; 37(4):1891-1899. PubMed ID: 28373457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. S100A7 overexpression is a predictive marker for high risk of malignant transformation in oral dysplasia.
    Kaur J; Matta A; Kak I; Srivastava G; Assi J; Leong I; Witterick I; Colgan TJ; Macmillan C; Siu KW; Walfish PG; Ralhan R
    Int J Cancer; 2014 Mar; 134(6):1379-88. PubMed ID: 24122701
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stromelysin 3, Ets-1, and vascular endothelial growth factor expression in oral precancerous and cancerous lesions: correlation with microvessel density, progression, and prognosis.
    Arora S; Kaur J; Sharma C; Mathur M; Bahadur S; Shukla NK; Deo SV; Ralhan R
    Clin Cancer Res; 2005 Mar; 11(6):2272-84. PubMed ID: 15788677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of hypoxia-inducible factor-1 alpha is significantly associated with the progression and prognosis of oral squamous cell carcinomas in Taiwan.
    Lin PY; Yu CH; Wang JT; Chen HH; Cheng SJ; Kuo MY; Chiang CP
    J Oral Pathol Med; 2008 Jan; 37(1):18-25. PubMed ID: 18154573
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Joint detection of claudin-1 and junctional adhesion molecule-A as a therapeutic target in oral epithelial dysplasia and oral squamous cell carcinoma.
    Upadhaya P; Barhoi D; Giri A; Bhattacharjee A; Giri S
    J Cell Biochem; 2019 Oct; 120(10):18117-18127. PubMed ID: 31161679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of vascular endothelial growth factor is significantly associated with progression and prognosis of oral squamous cell carcinomas in Taiwan.
    Cheng SJ; Lee JJ; Kok SH; Chou CH; Chang HH; Yang H; Chiang ML; Kuo MY
    J Formos Med Assoc; 2011 Jan; 110(1):50-7. PubMed ID: 21316013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased ΔNp63 expression is predictive of malignant transformation in oral epithelial dysplasia and poor prognosis in oral squamous cell carcinoma.
    Matsubara R; Kawano S; Kiyosue T; Goto Y; Hirano M; Jinno T; Toyoshima T; Kitamura R; Oobu K; Nakamura S
    Int J Oncol; 2011 Dec; 39(6):1391-9. PubMed ID: 21833468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor expression of miR-448 is a prognostic marker in oral squamous cell carcinoma.
    Wei H; Yu K; Liu Y; Li L; Wang G
    BMC Cancer; 2020 Aug; 20(1):756. PubMed ID: 32787801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.